FMP
NASDAQ
2.59 USD
0.13 (5.02%)
Mr. Michael K. McGarrity
Healthcare
Diagnostics & Research
https://mdxhealth.com
NASDAQ
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.
0001872529
US58286E1029
58286E102
CAP Business Center
32 4 257 70 21
BE
252
Nov 4, 2021
0001872529
NASDAQ
Diagnostics & Resear...
Healthcare
58286E102
US58286E1029
BE
2.59
-379.68k
73.68k
70.68M
-
0.35-4.64
0
-
-
-
-
-1.23
-
https://mdxhealth.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.